Block listing Interim Review
Summary by AI BETAClose X
Dr. Martens plc has reported its six-month block listing return for employee share plans, showing a decrease in unallotted securities. The company began the period from June 1, 2025, to November 30, 2025, with 14,601,047 shares available. During this period, 1,852,112 shares were issued or allotted under the schemes, resulting in a remaining balance of 12,748,935 unallotted shares at the end of the reporting period.
Dr. Martens PLC
01 December 2025
Dr. Martens plc
('Dr. Martens', 'the Company')
BLOCK LISTING SIX MONTHLY RETURN
Date: 1 DECEMBER 2025
|
Name of applicant: |
DR. MARTENS PLC |
|||
|
Name of scheme: |
DR. MARTENS PLC'S EMPLOYEE SHARE PLANS |
|||
|
Period of return: |
From: |
1 JUNE 2025 |
To: |
30 NOVEMBER 2025 |
|
Balance of unallotted securities under scheme(s) from previous return: |
14,601,047 SHARES |
|||
|
Plus: The amount by which the block scheme(s) has been increased since the date of the last return (if any increase has been applied for): |
N/A |
|||
|
Less: Number of securities issued/allotted under scheme(s) during period (see UKLR 20.6.7G): |
1,852,112 SHARES |
|||
|
Equals: Balance under scheme(s) not yet issued/allotted at end of period: |
12,748,935 SHARES |
|||
|
Name of contact: |
PAUL ROLLING |
|
Telephone number of contact: |
+447584243562 |
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
Latest directors dealings
- 5 hours ago Oxford Nanopore Technologies
- 6 hours ago AVI Global Trust
- 6 hours ago LSL Property Services
- 6 hours ago Bluebird Merchant Ventures (DI)
- 6 hours ago Power Probe PLC